CLINICAL_TRIALS
trial_result
· 2017-08-24
Clinical Trial Update: Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-BIA 9-1067 [Phase 1]
Summary
Phase 1 study presenting mass balance recovery, metabolite profiling, and metabolite identification data for [14C]-BIA 9-1067 in Parkinson disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bial - Portela C S.A. | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED